Citation only
via Europe PMC
Longevity Factor Klotho and Resistance to Cognitive Deficits in Individuals with Parkinson's Disease and in an α-Synuclein Mouse Model.
Luthra NS, Bonham LW, Moreno AJ, Park C, Huguenard CJC, Abdulai-Saiku S, Gupta S, Lin J, Broestl L, Bétourné A, Sehgal R, Wang D, Lesné SE, Ostrem JL, Yokoyama JS
The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
Abstract
Aging is the primary risk factor for Parkinson's disease (PD), and PD-related cognitive impairment remains a major unmet biomedical challenge. Klotho, a pleiotropic protein, extends lifespan and enhances cognition, but whether it confers resilience to cognitive impairments in PD is unclear. Here, we show that in humans, the KL-VS genetic variant of <i>KLOTHO</i>, linked to higher circulating klotho levels, associated with better executive cognition in individuals with PD across two independent cohorts. To test causality and explore mechanisms, we turned to mouse models. Transgenic elevation of klotho in a mouse model increased lifespan, improved synaptic and cognitive, but not motor, functions in mice, and decreased steady-state α-synuclein (α-syn) levels in the brains of male mice expressing wild-type human α-syn. Complementary in vitro studies showed that klotho rescued α-syn-induced deficits in NMDAR-dependent signaling through GluN2B and augmented α-syn microglial-related uptake, suggesting a potential mechanism by which klotho counters PD-related toxicity. Together, these findings indicate that klotho can counteract cognitive deficits related to PD, possibly by modulating α-syn levels, and these findings may be relevant to new therapeutic pathways for PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1523/jneurosci.1904-25.2026
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
NS, L., LW, B., AJ, M., C, P., CJC, H., S, A., S, G., J, L., L, B., A, B., R, S., D, W., SE, L., JL, O., JS, Y., & DB., D. (2026). Longevity Factor Klotho and Resistance to Cognitive Deficits in Individuals with Parkinson's Disease and in an α-Synuclein Mouse Model. <em>The Journal of neuroscience : the official journal of the Society for Neuroscience</em>. https://doi.org/10.1523/jneurosci.1904-25.2026
Vancouver
NS L, LW B, AJ M, C P, CJC H, S A, et al. Longevity Factor Klotho and Resistance to Cognitive Deficits in Individuals with Parkinson's Disease and in an α-Synuclein Mouse Model. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2026. doi:10.1523/jneurosci.1904-25.2026.
BibTeX
@article{luthra2026Longev,
title = {Longevity Factor Klotho and Resistance to Cognitive Deficits in Individuals with Parkinson's Disease and in an α-Synuclein Mouse Model.},
author = {Luthra NS and Bonham LW and Moreno AJ and Park C and Huguenard CJC and Abdulai-Saiku S and Gupta S and Lin J and Broestl L and Bétourné A and Sehgal R and Wang D and Lesné SE and Ostrem JL and Yokoyama JS and Dubal DB.},
journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
year = {2026},
doi = {10.1523/jneurosci.1904-25.2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2011
Open access · CC-BY
Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
PLoS ONE 2011
Open access · CC-BY
Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
PLoS ONE 2010
Open access · CC-BY
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
Nature Aging 2023
Open access · CC-BY
Longevity factor klotho enhances cognition in aged nonhuman primates
Brain and Behavior 2022
Open access · CC-BY
Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
American Journal of Physiology-Heart and Circulatory Physiology 2019
Open access · OA